Key result
OMsignal wearable ECG delivers signal quality comparable to standard Holter monitoring.
Why the study?
Diagnosis of arrhythmic disorders is challenging due to their intermittent character, and conventional noninvasive ambulatory rhythm monitoring has modest sensitivity.
Does the OMsignal wearable ECG sensor system provide equivalent signal quality and R-R coverage compared to a standard 3-lead Holter in healthy individuals?
Does the OMsignal wearable ECG sensor system provide equivalent signal quality and R-R coverage compared to a standard 3-lead Holter in healthy individuals?
The OMsignal wearable ECG garment provides comparable signal quality and heart rate accuracy to a standard 3-lead Holter, demonstrating proof-of-concept for its use in long-term ambulatory rhythm monitoring.
Answers are grounded in this paper and cite their sources.
Supports wearable ECG feasibility in healthy subjects; leaves open validation for arrhythmia detection in patients.
Diagnosis of arrhythmic disorders is challenging because of their short-lasting, intermittent character. Conventional technologies of noninvasive ambulatory rhythm monitoring are limited by modest sensitivity. We present a novel form of wearable electrocardiogram (ECG) sensors providing an alternative tool for long-term rhythm monitoring with the potential of increased sensitivity to detect intermittent or subclinical arrhythmia. The objective was to assess the signal quality and R-R coverage of a wearable ECG sensor system compared to a standard 3-lead Holter. In this phase-1 trial, healthy individuals underwent 24-h simultaneous rhythm monitoring using the OMsignal system together with a 3-lead Holter recording. The OMsignal system consists of a garment (bra or shirt) with integrated sensors recording a single-lead ECG and an acquisition module for data storage and processing. Head-to-head signal quality was assessed regarding adequate P-QRS-T distinction and was performed by three electrophysiologists blinded to the recording technology. The accuracy of signal coverage was assessed using Bland-Altman analysis. Fifteen individuals underwent simultaneous 24-h recording. Signal quality and accuracy of the OMgaments was equivalent to Holter-monitoring (84% vs. 93% electrophysiologists rating, p = 0.06). Signal coverage of R-R intervals showed a very close overlay between the OMsignal system and Holter signals, mean difference in heart rate of 2 ± 5 bpm. The noise level of OMgarments was comparable to Holter recording. OMgarments provide high signal quality for adequate rhythm analysis, representing a promising novel technology for long-term non-invasive ECG monitoring.
No takes yet. Share an insight, caveat, or question.
Steinberg et al. (2019) studied this question. The OMsignal wearable ECG system demonstrated signal quality comparable to standard Holter monitoring with an 84% vs. 93% accuracy rating (p = 0.06).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: